An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)
Status:
Completed
Trial end date:
2006-07-31
Target enrollment:
Participant gender:
Summary
A study to determine the safety, tolerability, and anti-tumor effectiveness of an oral
investigational drug in the treatment of relapsed diffuse large B-cell lymphoma.